We are live on
!
Find out more
NM
Newtyn Management Portfolio holdings
AUM
$936M
1-Year Est. Return
27.23%
This Fund
S&P 500
This Quarter
Est. Return
-13.81%
1 Year Est. Return
+27.23%
3 Year Est. Return
+51.99%
5 Year Est. Return
+55.23%
10 Year Est. Return
+165.15%
AUM
$528M
AUM Growth
+$110M
(+26%)
Cap. Flow
+$174M
Cap. Flow
% of AUM
32.89%
Top 10 Holdings %
Top 10 Hldgs %
50.68%
Holding
87
New
48
Increased
19
Reduced
11
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cannae Holdings
CNNE
|
+$29.4M |
| 2 |
PPLI
People Inc
PPLI
|
+$28.8M |
| 3 |
Ardagh Metal Packaging
AMBP
|
+$25.5M |
| 4 |
ONL
Orion Office REIT
ONL
|
+$15.6M |
| 5 |
Lamb Weston
LW
|
+$9.91M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LYLT
Loyalty Ventures Inc. Common Stock
LYLT
|
+$9.48M |
| 2 |
RLJ Lodging Trust $1.95 Series A Preferred Stock
RLJ.PRA
|
+$6.69M |
| 3 |
PG&E
PCG
|
+$5.41M |
| 4 |
TSVT
2seventy bio
TSVT
|
+$3.28M |
| 5 |
Algoma Steel
ASTL
|
+$2.62M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.3% |
| 2 | Consumer Discretionary | 16.93% |
| 3 | Financials | 13.63% |
| 4 | Real Estate | 8.52% |
| 5 | Technology | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Kodiak Sciences
KOD
$2.6B
| $5.54M | 1.05% |
+725,000
| New | +$5.09M |
|
27
Customers Bancorp
CUBI
$2.66B
| $5.08M | 0.96% |
150,000
| – | – |
|
28
uniQure
QURE
$3.03B
| $5.07M | 0.96% |
+272,091
| New | +$4.33M |
|
29
Tilly's
TLYS
$116M
| $4.35M | 0.82% |
620,000
+120,000
| +24% | +$1M |
|
|
NXDT
30
NexPoint Diversified Real Estate Trust
NXDT
$234M
| $4.12M | 0.78% |
250,000
-50,000
| -17% | -$776K |
|
|
SFIX
31
Stitch Fix
SFIX
$536M
| $4.08M | 0.77% |
825,000
+525,000
| +175% | +$4.39M |
|
|
RDUS
32
DELISTED
Radius Health, Inc.
RDUS
| $3.96M | 0.75% |
+381,998
| New | +$2.84M |
|
|
33
RLJ Lodging Trust $1.95 Series A Preferred Stock
RLJ.PRA
$326M
| $3.26M | 0.62% |
125,607
-254,393
| -67% | -$6.69M |
|
34
Destination XL Group
DXLG
$31.2M
| $3.05M | 0.58% |
900,000
-115,097
| -11% | -$518K |
|
|
DNMR
35
DELISTED
Danimer Scientific, Inc.
DNMR
| $2.85M | 0.54% |
15,625
+3,125
| +25% | +$568K |
|
|
IVAC
36
DELISTED
Intevac Inc
IVAC
| $2.44M | 0.46% |
504,035
+104,035
| +26% | +$530K |
|
37
Comp X International
CIX
$349M
| $2.32M | 0.44% |
100,000
-54,636
| -35% | -$1.22M |
|
38
Phathom Pharmaceuticals
PHAT
$708M
| $2.16M | 0.41% |
+255,767
| New | +$2.63M |
|
39
Olema Pharmaceuticals
OLMA
$1B
| $2.04M | 0.39% |
+500,000
| New | +$1.59M |
|
|
TCRR
40
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $2.01M | 0.38% |
+692,799
| New | +$1.71M |
|
41
CytomX Therapeutics
CTMX
$675M
| $1.96M | 0.37% |
+1,073,400
| New | +$2.06M |
|
42
Pyxis Oncology
PYXS
$168M
| $1.9M | 0.36% |
+800,000
| New | +$2.13M |
|
43
Collegium Pharmaceutical
COLL
$1.15B
| $1.86M | 0.35% |
+105,000
| New | +$1.77M |
|
|
CYT
44
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $1.81M | 0.34% |
+606,248
| New | +$1.55M |
|
|
ALR
45
DELISTED
AlerisLife Inc
ALR
| $1.8M | 0.34% |
1,500,000
| – | – |
|
46
AtaiBeckley Inc
ATAI
$2.66B
| $1.71M | 0.32% |
470,000
+219,864
| +88% | +$899K |
|
|
LTCH
47
DELISTED
Latch, Inc. Common Stock
LTCH
| $1.71M | 0.32% |
1,500,000
+843,940
| +129% | +$2.16M |
|
48
American Express Global Business Travel
GBTG
$4.93B
| $1.55M | 0.29% |
+245,208
| New | +$2.15M |
|
49
Bolt Biotherapeutics
BOLT
$7.67M
| $1.53M | 0.29% |
+37,413
| New | +$1.45M |
|
50
Passage Bio
PASG
$14.4M
| $1.46M | 0.28% |
+31,000
| New | +$1.45M |
|
Similar funds
APM
PWAM
NI
MCM
TS
TW
PGA
FPI
Newtyn Management's Q2 2022 Portfolio in Review
As of Q2 2022, Newtyn Management held 87 positions worth $528M, up 26% from $418M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Newtyn Management deployed $174M of net new capital in Q2 2022, opening 48 new positions and adding to 19 existing holdings. Its largest new stake was Cannae Holdings: 1,400,000 shares worth $27.1M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was RLJ Lodging Trust $1.95 Series A Preferred Stock, an estimated $6.69M trimmed.
- Newtyn Management's largest Q2 2022 buy was Cannae Holdings: 1,400,000 shares worth $27.1M.
- Newtyn Management added most to Ardagh Metal Packaging in Q2 2022, an estimated $25.5M increase.
- Newtyn Management's biggest Q2 2022 reduction was RLJ Lodging Trust $1.95 Series A Preferred Stock, cutting an estimated $6.69M.
- Newtyn Management fully exited Loyalty Ventures Inc. Common Stock in Q2 2022, selling an estimated $9.48M.
- Newtyn Management's ten largest holdings make up 51% of its $528M portfolio in Q2 2022.
- Newtyn Management opened 48 new positions and closed 3 in Q2 2022.
- Newtyn Management's portfolio value rose 26% quarter-over-quarter to $528M.
Based on Newtyn Management's 13F filing for Q2 2022, filed 15 Aug 2022.